FDA Grants Priority Review to Nubeqa for Metastatic Prostate Cancer

Press/Media

Period	May 4 2022

Media coverage

Title	FDA Grants Priority Review to Nubeqa for Metastatic Prostate Cancer
Media name/outlet	DocWireNews
Country/Territory	United States
Date	05/4/22
URL	https://www.docwirenews.com/gu-oncology-now/gu-oncology-now-picks/priority-review-granted-to-nubeqa/
Persons	Matthew R. Zibelman